Zoetis Inc (ZTS)
176.96
+0.25
(+0.14%)
USD |
NYSE |
Nov 22, 16:00
176.96
0.00 (0.00%)
Pre-Market: 04:10
Zoetis Debt to Equity Ratio: 1.256 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.256 |
| June 30, 2024 | 1.322 |
| March 31, 2024 | 1.302 |
| December 31, 2023 | 1.314 |
| September 30, 2023 | 1.291 |
| June 30, 2023 | 1.418 |
| March 31, 2023 | 1.460 |
| December 31, 2022 | 1.794 |
| September 30, 2022 | 1.408 |
| June 30, 2022 | 1.435 |
| March 31, 2022 | 1.412 |
| December 31, 2021 | 1.451 |
| September 30, 2021 | 1.409 |
| June 30, 2021 | 1.654 |
| March 31, 2021 | 1.759 |
| December 31, 2020 | 1.910 |
| September 30, 2020 | 2.137 |
| June 30, 2020 | 2.580 |
| March 31, 2020 | 2.348 |
| December 31, 2019 | 2.381 |
| September 30, 2019 | 2.407 |
| June 30, 2019 | 2.674 |
| March 31, 2019 | 2.781 |
| December 31, 2018 | 2.953 |
| September 30, 2018 | 3.041 |
| Date | Value |
|---|---|
| June 30, 2018 | 2.515 |
| March 31, 2018 | 2.528 |
| December 31, 2017 | 2.798 |
| September 30, 2017 | 2.867 |
| June 30, 2017 | 2.664 |
| March 31, 2017 | 2.777 |
| December 31, 2016 | 3.005 |
| September 30, 2016 | 2.818 |
| June 30, 2016 | 3.293 |
| March 31, 2016 | 3.835 |
| December 31, 2015 | 4.558 |
| September 30, 2015 | 2.957 |
| June 30, 2015 | 3.101 |
| March 31, 2015 | 2.852 |
| December 31, 2014 | 2.770 |
| September 30, 2014 | 2.677 |
| June 30, 2014 | 2.90 |
| March 31, 2014 | 3.396 |
| December 31, 2013 | 3.890 |
| September 30, 2013 | 4.332 |
| June 30, 2013 | 4.565 |
| March 31, 2013 | 5.142 |
| December 31, 2012 | 0.1446 |
| September 30, 2012 | 0.1417 |
| June 30, 2012 | 0.1464 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.256
Minimum
Sep 2024
2.580
Maximum
Jun 2020
1.652
Average
1.443
Median
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7219 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
| Vertex Pharmaceuticals Inc | 0.00 |
| Alnylam Pharmaceuticals Inc | 31.64 |
| Biomarin Pharmaceutical Inc | 0.1098 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.36B |
| Total Liabilities (Quarterly) | 9.123B |
| Shareholders Equity (Quarterly) | 5.234B |
| Current Ratio | 3.691 |
| Net Debt Paydown Yield | -0.00% |